| Primary |
| Attention Deficit/hyperactivity Disorder |
73.3% |
| Depression |
9.3% |
| Asthenia |
5.3% |
| Narcolepsy |
5.3% |
| Hypertension |
2.7% |
| Adhd |
1.3% |
| Cataplexy |
1.3% |
| Psychomotor Hyperactivity |
1.3% |
|
| Tic |
16.7% |
| Suicidal Ideation |
14.3% |
| Convulsion |
7.1% |
| Ventricular Fibrillation |
7.1% |
| Weight Decreased |
7.1% |
| Drug Ineffective |
4.8% |
| Euphoric Mood |
4.8% |
| Glaucoma |
4.8% |
| Intussusception |
4.8% |
| Tumour Excision |
4.8% |
| Adrenomegaly |
2.4% |
| Agitation |
2.4% |
| Altered State Of Consciousness |
2.4% |
| Arrhythmia |
2.4% |
| Atrial Fibrillation |
2.4% |
| Bronchospasm |
2.4% |
| Cardiomyopathy |
2.4% |
| Chest Pain |
2.4% |
| Contusion |
2.4% |
| Deafness |
2.4% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
76.4% |
| Depression |
7.9% |
| Asthenia |
4.5% |
| Bipolar Disorder |
4.5% |
| Drug Use For Unknown Indication |
2.2% |
| Schizophrenia |
2.2% |
| Acne |
1.1% |
| Anxiety |
1.1% |
|
| Weight Decreased |
25.7% |
| Convulsion |
11.4% |
| Suicidal Ideation |
8.6% |
| Tic |
8.6% |
| Pharmaceutical Product Complaint |
5.7% |
| Tumour Excision |
5.7% |
| Blood Testosterone Decreased |
2.9% |
| Cardiac Arrest |
2.9% |
| Drug Ineffective |
2.9% |
| Dystonia |
2.9% |
| Glaucoma |
2.9% |
| Growth Retardation |
2.9% |
| Heart Rate Increased |
2.9% |
| Medication Error |
2.9% |
| Muscle Rigidity |
2.9% |
| Skin Exfoliation |
2.9% |
| Tongue Biting |
2.9% |
| Treatment Noncompliance |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.3% |
| Attention Deficit/hyperactivity Disorder |
14.4% |
| Asthma |
6.2% |
| Depression |
5.9% |
| Insomnia |
4.6% |
| Arthritis |
3.9% |
| Sleep Disorder |
3.6% |
| Autism |
3.3% |
| Bipolar Disorder |
3.3% |
| Contraception |
2.6% |
| Pain |
2.6% |
| Abnormal Behaviour |
2.0% |
| Anxiety |
2.0% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Multiple Allergies |
1.6% |
| Oppositional Defiant Disorder |
1.6% |
| Rhinitis Allergic |
1.6% |
| Autoimmune Thyroiditis |
1.3% |
| Body Height Below Normal |
1.3% |
| Breast Cancer Metastatic |
1.3% |
|
| Somnambulism |
19.6% |
| Anaphylactic Reaction |
9.8% |
| Weight Increased |
9.8% |
| Staphylococcal Infection |
7.8% |
| Type 2 Diabetes Mellitus |
5.9% |
| Ventricular Hypertrophy |
5.9% |
| Poor Quality Drug Administered |
3.9% |
| Product Quality Issue |
3.9% |
| Psychotic Disorder |
3.9% |
| Restlessness |
3.9% |
| Sleep-related Eating Disorder |
3.9% |
| Vertigo |
3.9% |
| Visual Impairment |
3.9% |
| Aggression |
2.0% |
| Anxiety |
2.0% |
| Asthma |
2.0% |
| Breast Tenderness |
2.0% |
| Cardiac Arrest |
2.0% |
| Chest Pain |
2.0% |
| Constipation |
2.0% |
|
